Synovis Life Technologies — Merger or Acquisition (December 2011)
9 slides from Synovis Life Technologies's merger presentation, Dec 13, 2011
Slide 1: Baxter BioSciences and Synovis: An Exciting Combination
Baxter BioSciences and Synovis An Exciting Combination
Slide 2: Baxter and Synovis
Baxter and Synovis • What has just happened? • How did this come about? • Why did this happen? • What will happen now? And When? • What does this mean for you?
Slide 3: What Has Just Happened?
What Has Just Happened? • Baxter BioSciences and Synovis Life Technologies entered into a definitive agreement • The agreement is subject to shareholder approval • The agreement is for the BioSciences Division of Baxter to acquire all of Synovis.
Slide 4: How did this come about?
How did this come about? • Synovis was not seeking a buyer - we were not for sale • Baxter approached Synovis with a proposal we believed might be in the best interests of our Shareholders • Baxter saw synergistic opportunities for the combination of our businesses and made a compelling offer to buy
Slide 5: Why did this come about?
Why did this come about? $ in millions
Slide 6: What will happen now? And when?
What will happen now? And when? We will continue to be Synovis, an independent company, until the shareholders approve the acquisition We expect the shareholder vote to occur in the last half of the calendar first quarter We will come to work tomorrow and continue to do our jobs as we always have an
Slide 7: What does this mean for you?
What does this mean for you? Between now and the closing date, which is expected by the end of March, it will be business as usual As an integration plan is developed, people from Synovis will be included in the planning process The goal will be to bring the best processes, practices, and people fro
Slide 8: Synovis Life Technologies
Syn@vis Life Technologies Synovis Life Technologies, Inc. 25 Years of Growth oP Trust Mutual Respect High Communication=»Spirit of Cooperation
Slide 9: Additional Information and Where to Find It
Additional Information and Where to Find It In connection with the proposed acquisition and required shareholder approval, Synovis will file with the SEC a proxy statement. The proxy statement will be mailed to the shareholders of Synovis. Synovis’s shareholders are urged to read the proxy statement
Synovis Life Technologies — Merger or Acquisition (December 2011) on 6ix